DocGo Inc. Price/Book Ratio
The price-to-book (P/B) ratio compares what the stock market says a company is worth with what the company's own books say it is worth. It is market capitalization divided by shareholder equity, the book value left after subtracting liabilities from assets, and the table shows both amounts. A ratio of 1.0 means market value equals book value; a higher ratio means investors value the company above its net assets, often for brands, software or expected growth the books do not record. A negative ratio means equity is negative. Each point uses the filed share count and the last closing price on or before the equity's reporting date, never today's price.
- DocGo Inc. price/book ratio for the quarter ending 2026-06-30 was 0.43, a 15.80% decline year-over-year.
- DocGo Inc. price/book ratio for the quarter ending 2026-03-31 was 0.47, a 45.04% decline year-over-year.
- DocGo Inc. price/book ratio for the quarter ending 2025-12-31 was 0.6, a 55.49% decline year-over-year.
- DocGo Inc. price/book ratio for the quarter ending 2025-09-30 was 0.49, a 52.60% decline year-over-year.
- DocGo Inc. price/book ratio for fiscal 2026 was 0.43.
- DocGo Inc. price/book ratio for fiscal 2025 was 0.6, a 55.49% decline from fiscal 2024.
- DocGo Inc. price/book ratio for fiscal 2024 was 1.35, a 30.37% decline from fiscal 2023.
- DocGo Inc. price/book ratio for fiscal 2023 was 1.93, a 27.03% decline from fiscal 2022.
- Available history
- 2020-12-31 to 2026-06-30
- Data captured
Historical Price/Book Ratio
Annual Price/Book Ratio
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |